malondialdehyde has been researched along with Multiple Sclerosis in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.51) | 18.7374 |
| 1990's | 5 (13.51) | 18.2507 |
| 2000's | 4 (10.81) | 29.6817 |
| 2010's | 18 (48.65) | 24.3611 |
| 2020's | 5 (13.51) | 2.80 |
| Authors | Studies |
|---|---|
| Bapir, AA; Hamad, MS; Iqbal, ZM; Ismaeal, YS; Kaleem, M; Khudhur, ZO; Mohammad, KA; Omar, SA; Qadir, MK; Qureshi, AS; Rajab, MF; Rasoul, AA; Rasul, MF; Rizwan, MA; Salihi, A; Smail, SW | 1 |
| Biswas, S; Dalal, V; Pathak, A; Paul, A; Ramani, S | 1 |
| Jin, L; Liu, C; Loers, G; Petridis, AK; Siebert, HC; Wang, Z; Zhang, N; Zhang, R; Zheng, X | 1 |
| Andjelic, T; Dejanovic, B; Kotur-Stevuljevic, J; Ninkovic, M; Obradovic, D | 1 |
| Abdelghani, AA; Elsharkawi, KA; Ghonimi, NAM; Khyal, DSM | 1 |
| Abolhassani, J; Afarini, M; Asemi, Z; Bahmani, F; Kouchaki, E; Masoud, SA; Mirhosseini, N | 1 |
| Azimi, A; Eghtesadi, S; Eskandari, G; Khalili, M; Mirshafiey, A; Moftakhar, S; Motevalian, A; Norouzi, A; Sahraian, MA; Sanoobar, M | 1 |
| Ahmadi, Y; Faghfoori, Z; Ghorbanihaghjo, A; irannejad, VS; Yousefi, B | 1 |
| Borgiani, B; Cavarretta, R; Clerici, M; Comi, G; Cursano, C; Furlan, R; Gironi, M; Mariani, E; Mendozzi, L; Rovaris, M; Saresella, M | 1 |
| Adamczyk-Sowa, M; Hartel, M; Kukla, M; Pierzchala, K; Polaniak, R; Sowa, P | 1 |
| Lutsky, MA; Razinkin, KA; Zemskov, AM | 1 |
| Cruickshank, TM; Reyes, AR; Ziman, MR | 1 |
| Abramsky, O; Binyamin, O; Frid, K; Friedman-Levi, Y; Gabizon, R; Keller, G; Larush, L; Magdassi, S; Ovadia, H | 1 |
| Bartova, R; Durfinova, M; Liska, B; Oresanska, K; Petrlenicova, D; Prochazkova, L; Turecky, L | 1 |
| Hares, K; Ibitoye, R; Kemp, K; Rice, C; Scolding, N; Wilkins, A | 1 |
| Akbari, E; Asemi, Z; Bahmani, F; Daneshvar Kakhaki, R; Jafari, P; Kouchaki, E; Salami, M; Tajabadi-Ebrahimi, M; Tamtaji, OR | 1 |
| Alizadeh-Ghodsi, M; Ebrahimi-Kalan, A; Shiri-Shahsavar, MR; Yousefi, B; Zavvari, A | 1 |
| Alifirova, VM; Ivanova, SA; Krotenko, NV | 1 |
| Al-E-Eshagh, N; Asadi, F; Ghabaee, M; Ghaffarpour, M; Jabedari, B | 1 |
| Bauer, J; Binder, CJ; Botond, G; Esterbauer, H; Fischer, MT; Frischer, JM; Haider, L; Höftberger, R; Lassmann, H; Witztum, JL | 1 |
| Berlanga, J; Brown, E; Coro-Antich, RM; del Barco, DG; Lopez, L; Montero, E; Suarez-Alba, J; Subirós, N | 1 |
| Acar, A; Arıkanoglu, A; Evliyaoglu, O; Onder, H; Tamam, Y; Taşdemir, N; Ugur Cevik, M; Uzar, E; Varol, S; Yucel, Y | 1 |
| Boada, J; Brieva, L; Cacabelos, D; Cassanyé, A; González, C; Gonzalo, H; Hernández, L; Jové, M; Lanau-Angulo, L; Pamplona, R; Peralta, S; Portero-Otin, M; Serrano, JC; Tatzber, F | 1 |
| Adamczyk-Sowa, M; Labuz-Roszak, B; Pierzchala, K; Polaniak, R; Sowa, P | 1 |
| Lutskiĭ, MA; Razinkin, KA; Zemskov, AM | 1 |
| Moreira, PI; Perry, G; Sayre, LM; Smith, MA | 1 |
| Khokhlov, AP; Rogovina, NI | 1 |
| Arduini, A; Di Ilio, C; Federici, G; La Rovere, G; Polidoro, G | 1 |
| Khokhlov, AP; Mel'nichuk, PV; Rogovina, NI | 1 |
| Cuzner, ML; Li, H; Newcombe, J | 1 |
| Calabrese, V; Cosentino, E; Raffaele, R; Rizza, V | 1 |
| Briuzhina, TS; Iurzhenko, NM; Sokolova, LI | 1 |
| Bencsik, K; Karg, E; Klivényi, P; Németh, I; Pintér, S; Vécsei, L | 1 |
| Akçay, F; Aksoy, H; Keles, MS; Sen, N; Taysi, S | 1 |
| Bagriĭ, EA; Bessmertnaia, EV; Nazarenko, VG | 1 |
| Czernicki, J; Gromadzińska, J; Maciejek, Z; Skłodowska, M; Wasowicz, W; Zachara, BA | 1 |
| Davidson, DL; Hunter, MI; Nlemadim, BC | 1 |
4 review(s) available for malondialdehyde and Multiple Sclerosis
| Article | Year |
|---|---|
Oxidative Stress in Autoimmune Diseases: An Under Dealt Malice.
Topics: Arthritis, Rheumatoid; Autoantibodies; Autoimmunity; Diabetes Mellitus, Type 1; Gene Expression; Genetic Predisposition to Disease; HLA Antigens; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Malondialdehyde; Multiple Sclerosis; Oxidative Stress; Reactive Oxygen Species; Receptors, Fc | 2020 |
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
Topics: Biomarkers; Disease Progression; Electromyography; Fatigue; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Malondialdehyde; Mobility Limitation; Multiple Sclerosis; Muscle Strength; Parkinson Disease; Postural Balance; Quality of Life; Resistance Training; Superoxide Dismutase | 2015 |
Oxidative stress-related biomarkers in multiple sclerosis: a review.
Topics: Biomarkers; DNA; Humans; Malondialdehyde; Multiple Sclerosis; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Protein Carbonylation; Superoxide Dismutase | 2016 |
Metal ions and oxidative protein modification in neurological disease.
Topics: Aldehydes; alpha-Synuclein; Alzheimer Disease; Animals; Cross-Linking Reagents; Encephalomyelitis, Autoimmune, Experimental; Free Radicals; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Malondialdehyde; Metals; Mice; Multiple Sclerosis; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Proteins; Rats; Reactive Oxygen Species | 2005 |
4 trial(s) available for malondialdehyde and Multiple Sclerosis
| Article | Year |
|---|---|
High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial.
Topics: Adult; Analgesics; Antioxidants; C-Reactive Protein; Cholecalciferol; Cholesterol; Cholesterol, HDL; Dietary Fats; Dietary Supplements; Disability Evaluation; Disabled Persons; Fatty Acids, Omega-3; Female; Glutathione; Humans; Inflammation; Insulin; Insulin Resistance; Malondialdehyde; Multiple Sclerosis; Oxidative Stress; Vitamins | 2018 |
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Antioxidants; Biomarkers; Double-Blind Method; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis; Oxidative Stress; Superoxide Dismutase; Thioctic Acid; Young Adult | 2014 |
Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
Topics: Adjuvants, Immunologic; Adult; Antioxidants; Dietary Supplements; Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Male; Malondialdehyde; Melatonin; Middle Aged; Mitoxantrone; Multiple Sclerosis; Neuropsychological Tests; Peptides; Quality of Life; Severity of Illness Index; Superoxide Dismutase; Young Adult | 2014 |
Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; C-Reactive Protein; Cholesterol; Dietary Supplements; Double-Blind Method; Female; Glutathione; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis; Nitric Oxide; Oxidative Stress; Probiotics; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2017 |
29 other study(ies) available for malondialdehyde and Multiple Sclerosis
| Article | Year |
|---|---|
The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population.
Topics: Humans; Lipid Peroxidation; Malondialdehyde; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress | 2021 |
Cuprizone-Induced Demyelination in Mouse Hippocampus Is Alleviated by Ketogenic Diet.
Topics: Animals; Astrocytes; Cuprizone; Demyelinating Diseases; Diet, Ketogenic; Disease Models, Animal; Glutathione; Hippocampus; Humans; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Oligodendroglia; PPAR gamma; Sirtuin 1 | 2020 |
Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis.
Topics: Adrenal Cortex Hormones; Advanced Oxidation Protein Products; Biomarkers; Female; Humans; Male; Malondialdehyde; Multiple Sclerosis; Oxidative Stress; Recurrence; Superoxide Dismutase | 2021 |
Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics.
Topics: Case-Control Studies; Humans; Lipid Peroxidation; Malondialdehyde; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | 2021 |
Serum arsenic and lipid peroxidation levels in patients with multiple sclerosis.
Topics: Adult; Arsenic; Case-Control Studies; Female; Humans; Malondialdehyde; Multiple Sclerosis; Spectrophotometry, Atomic; Thiobarbituric Acid Reactive Substances | 2014 |
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
Topics: Adult; Age Factors; Aged; Antibodies; Case-Control Studies; Female; Glatiramer Acetate; Glutathione; Humans; Immunologic Factors; Interferon-beta; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis; Oxidation-Reduction; Oxidative Stress; Peptides; Pilot Projects; Reactive Oxygen Species; Sex Factors; Ubiquinone | 2014 |
[Biochemical markers of oxidative stress in different forms and phases of multiple sclerosis].
Topics: Biomarkers; Case-Control Studies; Glutathione Peroxidase; Glutathione Reductase; Humans; Malondialdehyde; Multiple Sclerosis; Oxidative Stress; Schiff Bases; Superoxide Dismutase; Vitamin E | 2014 |
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Topics: Animals; Antioxidants; Brain; Demyelinating Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Lipids; Malondialdehyde; Mice, Inbred C57BL; Models, Biological; Multiple Sclerosis; Nanoparticles; Oxidation-Reduction; Particle Size; Plant Oils; Thiobarbituric Acid Reactive Substances | 2015 |
Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Biomarkers; Disease Progression; F2-Isoprostanes; Humans; Lipid Peroxidation; Malondialdehyde; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress | 2016 |
The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary.
Topics: Animals; Apoptosis; Arsenic; Brain; Cell Line; Disease Progression; Humans; Inflammation; Lipid Peroxidation; Malondialdehyde; Microtubules; Multiple Sclerosis; Neurons; Phosphorylation; Protein Aggregation, Pathological; tau Proteins | 2018 |
[Parameters of antioxidant protection in multiple sclerosis].
Topics: Adolescent; Adult; Antioxidants; Biomarkers; Catalase; Female; Follow-Up Studies; Humans; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis; Oxidative Stress; Prognosis; Remission Induction; Young Adult | 2009 |
Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.
Topics: Antioxidants; Case-Control Studies; Female; Guillain-Barre Syndrome; Humans; Lipid Peroxidation; Male; Malondialdehyde; Multiple Sclerosis | 2010 |
Oxidative damage in multiple sclerosis lesions.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD; Axons; Brain; DNA Damage; Female; Guanosine; Humans; Inflammation; Lipids; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis; Myelin Proteins; Nerve Tissue Proteins; Oligodendroglia; Oxidative Stress | 2011 |
Coadministration of epidermal growth factor and growth hormone releasing peptide-6 improves clinical recovery in experimental autoimmune encephalitis.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Epidermal Growth Factor; Female; Hormones; Insulin-Like Growth Factor I; Malondialdehyde; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Oligopeptides; Rats; Rats, Inbred Lew; Severity of Illness Index; Treatment Outcome | 2011 |
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Topics: Adult; Antioxidants; Case-Control Studies; Female; Humans; Male; Malondialdehyde; Multiple Sclerosis; Nitric Oxide; Oxidants; Oxidation-Reduction; Oxidative Stress; Superoxide Dismutase; Young Adult | 2012 |
Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism.
Topics: Adult; Autoantibodies; Cell Line, Transformed; Chromatography, High Pressure Liquid; Fatty Acids; Female; Glyoxal; Humans; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Male; Malondialdehyde; Mass Spectrometry; Metabolic Networks and Pathways; Middle Aged; Mucoproteins; Multiple Sclerosis; PPAR gamma; Protein Carbonylation; Pyruvaldehyde | 2012 |
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Biomarkers; Catalase; Enzymes; Glutathione Peroxidase; Humans; Lipid Peroxidation; Malondialdehyde; Mitoxantrone; Multiple Sclerosis; Oxidative Stress; Superoxide Dismutase; Time Factors; Treatment Outcome | 2012 |
[Early diagnosis of multiple sclerosis].
Topics: Adolescent; Adult; Antioxidants; Catalase; Ceruloplasmin; Clinical Enzyme Tests; Glutathione Peroxidase; Glutathione Reductase; Humans; Lipid Peroxidation; Malondialdehyde; Multiple Sclerosis; Risk Factors; Superoxide Dismutase; Time Factors; Vitamin E | 2002 |
[Metabolism of lipid peroxidation products in multiple sclerosis patients].
Topics: Adult; Alkadienes; Brain Neoplasms; Female; Humans; Lipid Peroxides; Male; Malonates; Malondialdehyde; Middle Aged; Multiple Sclerosis; Osteochondritis; Peripheral Nervous System Diseases; Spinal Cord Neoplasms; Spinal Diseases; Spinal Nerve Roots; Syndrome | 1980 |
Superoxide dismutase, reduced glutathione and TBA-reactive products in erythrocytes of patients with multiple sclerosis.
Topics: Erythrocytes; Glutathione; Humans; Lipid Peroxides; Malondialdehyde; Multiple Sclerosis; Superoxide Dismutase; Thiobarbiturates | 1984 |
[Changes of clinico-biochemical indicators in multiple sclerosis treated with hormones and antioxidants].
Topics: Adult; Female; Histidine; Humans; Lipid Peroxides; Male; Malonates; Malondialdehyde; Middle Aged; Multiple Sclerosis; Prednisolone | 1980 |
Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis.
Topics: Adult; Aged; Aldehydes; Astrocytes; Demyelinating Diseases; Humans; Immunohistochemistry; Lipoproteins, LDL; Macrophages; Malondialdehyde; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Oxidation-Reduction | 1994 |
Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis.
Topics: Antioxidants; Cerebrospinal Fluid Proteins; Glutathione Reductase; Humans; Male; Malondialdehyde; Multiple Sclerosis | 1994 |
[Lipid peroxidation in patients with multiple sclerosis].
Topics: Adult; Disease Progression; Fatty Acids; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis; Statistics, Nonparametric | 1997 |
Nonenzymatic antioxidants of blood in multiple sclerosis.
Topics: Adult; Antioxidants; Female; Free Radicals; Glutathione; Humans; Interferon-beta; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis | 1999 |
Effect of corticosteroid therapy on serum and CSF malondialdehyde and antioxidant proteins in multiple sclerosis.
Topics: Adolescent; Adult; Antioxidants; Ceruloplasmin; Female; Glucocorticoids; Humans; Lipid Peroxidation; Male; Malondialdehyde; Methylprednisolone; Middle Aged; Multiple Sclerosis; Transferrin | 2001 |
[The content of lipid peroxidation products in the blood of patients with disseminated sclerosis].
Topics: Adolescent; Adult; Chronic Disease; Drug Therapy, Combination; Female; Free Radicals; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis | 1990 |
Selenium status, glutathione peroxidase activity and lipid peroxides concentration in blood of multiple sclerosis patients.
Topics: Glutathione Peroxidase; Humans; Lipid Peroxides; Malondialdehyde; Multiple Sclerosis; Selenium | 1986 |
Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.
Topics: Antioxidants; Ceruloplasmin; Humans; Lipid Peroxides; Malondialdehyde; Multiple Sclerosis; Pigments, Biological; Spectrometry, Fluorescence; Transferrin | 1985 |